Logo

IBM Watson Health Reports Real-World Progress of AI in Oncology in #ASCO2019

Share this

IBM Watson Health Reports Real-World Progress of AI in Oncology in #ASCO2019

Shots:

  • IBM Watson has presented 22 new scientific studies showing progress in clinical studies of cancer using AI-Technology with informed decisions based on curated scientific evidences- insights and information which are unidentified manually and further leading to QoL
  • The presented data includes: Watson For Oncology lead to 13.6% changes in informs clinical decision reviewed by multidisciplinary tumor board; Watson For Genomics Surfaces resulted in new insights for oncologists to treat hematological malignancies; Watson For Oncology improves cancer patient confidence
  • Additionally- IBM Watson reported to identify automatically- high-quality and relevant scientific publications with the help of machine learning on words from abstracts of papers cited at three expert resources: NCCN- NCI-PDQ- and Hemonc.org further resulting in 93% accuracy- 95% sensitivity- and 91% specificity of treatment

Ref: IBM | Image: Japan Times

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions